CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- 4 Grant or award Director acquired 1,024 shares (grant or award)
- 4 Grant or award Director acquired 390 shares (grant or award)
- 4 Grant or award Director acquired 380 shares (grant or award)
- 4/A Grant or award President, R&D acquired 192,400 shares (grant or award)
- 4 Grant or award Director acquired 5,010 shares (grant or award)
- 4 Grant or award Director acquired 2,505 shares (grant or award)
- 4 Grant or award Director acquired 2,505 shares (grant or award)
- 4 Grant or award Director acquired 2,505 shares (grant or award)
- 4 Grant or award Director acquired 2,505 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 488 shares (to pay taxes)
- 4 Grant or award Director acquired 2,505 shares (grant or award)
- 4 Grant or award Director acquired 2,505 shares (grant or award)
- 4 Grant or award President, R&D acquired 179,613 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 326 shares (grant or award)
- 4 Grant or award Director acquired 318 shares (grant or award)
- 4 Grant or award Director acquired 858 shares (grant or award)
- 4 Exercise or conversion Director acquired 40,000 shares (option exercise)
- 4 Exercise or conversion EVP & Chief Scientific Officer acquired 3,693 shares (option exercise)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 1,179 shares (to pay taxes)
Page 16 of 82 · 1,628 filings